Clinical Trials for Kyverna Therapeutics

Explore 11 clinical trials worldwide

Showing 1-11 of 11 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Kyverna Therapeutics

Clinical Trials (11)

NCT06590545
Anti-CD 19 CAR-T Cell Therapy in Patients with ANCA Vasculitis
PHASE1/PHASE2Not yet recruiting
8 participants
Started: Jan 31, 2025 · Completed: Jul 31, 2027
1 condition2 sponsors0 locations
NCT06475495
Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis
PHASE1/PHASE2Not yet recruiting
13 participants
Started: Nov 30, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors0 locations
NCT06588491
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome
PHASE2Recruiting
25 participants
Started: Sep 25, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor3 locations
NCT06384976
KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
PHASE2Active, not recruiting
120 participants
Started: Sep 20, 2024 · Completed: Jan 31, 2029
4 conditions1 sponsor1 location
NCT06193889
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
PHASE2/PHASE3Recruiting
66 participants
Started: Aug 28, 2024 · Completed: Sep 30, 2028
2 conditions1 sponsor11 locations
NCT06400303
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
PHASE1/PHASE2Active, not recruiting
3 participants
Started: Aug 6, 2024 · Completed: Mar 31, 2027
3 conditions1 sponsor2 locations
NCT06152172
CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
PHASE1Active, not recruiting
24 participants
Started: Aug 5, 2024 · Completed: Feb 28, 2026
4 conditions2 sponsors1 location
NCT06451159
A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants with Treatment Refractory Progressive Multiple Sclerosis
PHASE1Active, not recruiting
10 participants
Started: Jun 20, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06138132
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis
PHASE1Active, not recruiting
12 participants
Started: Apr 10, 2024 · Completed: Jun 30, 2027
3 conditions2 sponsors1 location
NCT05938725
KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
PHASE1/PHASE2Recruiting
32 participants
Started: Apr 28, 2023 · Completed: Aug 31, 2026
3 conditions1 sponsor6 locations
NCT06342960
KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
PHASE1/PHASE2Recruiting
32 participants
Started: Dec 1, 2022 · Completed: Jan 31, 2029
3 conditions1 sponsor6 locations